Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cell Cycle/DNA Damage

Items 1-10 of 15

Page
per page
  1. BMS-1166
    BA6141 BMS-1166
    Summary: Potent PD-1/PD-L1 immune checkpoint inhibitor
  2. XAV-939
    A1877 XAV-939
     16 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 (TNKS) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  3. Valproic acid sodium salt
    A4099 Valproic acid sodium salt
    Target: Histone Deacetylases (HDACs)
    Summary: A class I HDAC inhibitor
      ≥8.35 mg/mL
  4. Streptozotocin
    A4457 Streptozotocin
     1 Citation
    Summary: Nitrosourea compound; for type 1 diabetes animal models
      ≥10.3 mg/mL
  5. Cyclophosphamide
    A2343 Cyclophosphamide
    Summary: Alkylating chemotherapeutic agent; crosslinks DNA
      ≥11.85 mg/mL
  6. Nifurpirinol
    BA1031 Nifurpirinol
    Summary: NTR substrate; for regeneration research and FSGS disease modeling
  7. Amrubicin
    A8227 Amrubicin
    Target: topoisomerase
    Summary: Amrubicin (SM-5887) is a DNA topoisomerase II inhibitor.
      ≥16.45 mg/mL
  8. Nudifloramide
    C8434 Nudifloramide
    Summary: PARP-1 inhibitor
      ≥6.75 mg/mL
  9. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil
    A9928 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil
    Summary: A nucleoside analogue that interferes with the synthesis of viral DNA or RNA
      ≥46.7 mg/mL
  10. HRO761
    A9929 HRO761
    Summary: A DNA helicase inhibitor
      ≥25.3 mg/mL

Items 1-10 of 15

Page
per page